What's new in IDIS:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Advisory Committee Meetings

 • Continuing Education Articles

 • Priority Clinical Practice Guidelines

 

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - February 2013

NEW DRUG TERM
ABT-333
ABT-450
ALX-270467
ANTI-CD122 MONOCLONAL AB
AVIBACTAM
BIIB-021
CINDUNISTAT
CISTANCHE DESERTICOLA
GNBAC1
GSK-1325756
GSK-1482160
HORSERADISH
ICOTINIB
JTK-853
LODENAFIL
METADOXINE
NASTURTIUM
OPORTUZUMAB MONATOX
OZ-439
RM-131
S-GSK-1265744
SCH-900776
SERELAXIN
SIGMA 1 RECEPTOR ANTAGONIST
SOFOSBUVIR
SRT-2104
TAK-683

CODE
8180127
8180128
44100111
10120304
44100112
10121049
44100113
92510294
82000574
92000391
28081305
92510292
10120305
8180125
24120110
92000390
92510293
10120303
8200025
56400047
8180905
10121047
68340004
28081304
8180126
92000389
10121048



DRUG NAME/CODE CHANGES

OLD TERM & CODE
ABT-869 10120921
WX-G250 10120241

NEW TERM & CODE
LINIFANIB 10120921
GIRENTUXIMAB 10120241


FDA APPROVAL PACKAGES

Article Numbers 690731-690746: Tofacitinib Citrate, Xeljanz, FDA Approval Package for NDA 203214. FDA Approval Package 2012.

Article Numbers 690575-690590: Cabozantinib, Cometriq, FDA Approval Package for NDA 203756. FDA Approval Package 2012.

Article Numbers 690559-690574: Ponatinib, Iclusig, FDA Approval Package for NDA 203469. FDA Approval Package 2012.


ADVISORY COMMITTEE MEETINGS

Article Numbers 690725-690730: Drug Safety and Risk Management Advisory Committee Meeting, December 13, 2012. FDA Advisory Committee 2012.

Article Numbers 690719-690724: Drug Safety and Risk Management Advisory Committee Meeting, December 12, 2012. FDA Advisory Committee 2012.

Article Numbers 690709-690718: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting, December 4, 2012. FDA Advisory Committee 2012.

Article Numbers 690702-690708: Arthritis Advisory Committee Meeting, December 20, 2012. FDA Advisory Committee 2012.

Article Numbers 690695-690701: Anesthetic and Analgesic Drug Products Advisory Committee Meeting, December 7, 2012. FDA Advisory Committee 2012.

Article Numbers 690688-690694: Anti-Infective Drugs Advisory Committee Meeting, November 29, 2012. FDA Advisory Committee 2012.

Article Numbers 690681-690687: Anti-Infective Drugs Advisory Committee Meeting, November 28, 2012. FDA Advisory Committee 2012.


CONTINUING EDUCATION ARTICLES

Article Number 691190: Cada D J, Ingram K T, Levien T L, Baker D E. Phentermine/Topiramate Extended Release (0.15 CEU). Hosp Pharm 2012, 47:950-958.

Article Number 690152: Anonymous. Probiotics Revisited (0.1 CEU). Med Lett Drugs Ther 2013, 55:3-4.

Article Number 690151: Anonymous. Tofacitinib (Xeljanz) for Rheumatoid Arthritis (0.1 CEU). Med Lett Drugs Ther 2013, 55:1-3.

Article Number 689983: Anonymous. Drugs for Acne, Rosacea, Psoriasis (0.2 CEU). Treat Guidel Med Lett 2013, 11:1-8.

Article Number 689671: Cada D J, Torres S, Levien T L, Baker D E. Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate Tablets (0.15 CEU). Hosp Pharm 2013, 48:48-56.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 691124: Barr J, Fraser G L, Puntillo K, Ely E W, et al. Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit: Executive Summary. Am J Health-Syst Pharm 2013, 70:53-58.


College of Pharmacy